Latest Strategic Investments News

Control Bionics Limited has announced a $2.06 million non-renounceable rights issue to fund the commercial expansion of its NeuroStrip device and bolster NeuroNode operations. The capital raise is underwritten to approximately $1.15 million by major shareholders and strategic partners.

Comms Group Limited reported a 2.1% revenue increase to $56.6 million for FY25, driven by organic growth and the strategic acquisition of TasmaNet. Despite this, underlying EBITDA declined 13.6%, reflecting investments and one-off revenue adjustments.

Tetratherix Limited reported a $9.4 million statutory loss for FY25 amid significant R&D and operational investments, successfully listing on the ASX and progressing multiple clinical and manufacturing initiatives.

Micro-X Limited reported a $13.9 million loss for FY2025 as it pivots towards medical imaging, securing a landmark supply agreement with a major US healthcare provider for its Rover Plus mobile X-ray system.

Knosys Limited reported steady FY25 revenue growth and secured major contract renewals, while investing heavily in AI-driven library technology that positions it for global expansion.

Swoop Holdings reported a 19.8% increase in revenue to $106.5 million for FY25, driven by organic growth and new contracts, but posted a wider net loss of $6.95 million. The company is reshaping its portfolio with divestments and major fibre network projects in Greater Melbourne.

Australian Ethical Investment Limited has delivered a standout FY25 with record funds under management and significant profit growth, setting the stage for its next growth phase.

SDI Limited reported a 16.7% rise in net profit after tax for FY2025, driven by improved gross margins and operational efficiencies despite a slight sales dip. The company maintained its dividend while investing in automation and new product development.

Appen Limited reported a 9.2% revenue decline to $103.2 million for H1 2025, offset by robust 67% growth in its China business unit. Despite increased net losses, the company maintains a strong cash position and focuses on generative AI expansion and operational efficiency.

Medibank has reported strong full-year results for 2025, with underlying net profit rising 8.5% and record policyholder growth, underpinned by disciplined cost management and strategic health investments.

Medibank Private Limited reported steady revenue growth and stable profit for FY25, while navigating ongoing cybercrime-related expenses and regulatory scrutiny. The insurer also announced increased dividends and outlined strategic investments in health services and digital transformation.

Ai-Media Technologies reported a 2.1% revenue decline to $64.86 million in FY25, driven by a strategic shift to technology sales and a 25% drop in services revenue. Despite a higher net loss, underlying EBITDA rose 11%, reflecting progress in its SaaS transformation and global expansion.